Cardiovascular risk factor trends and potential for reducing coronary heart disease mortality in the United States of America

Bulletin of the World Health Organization

Volumn 88, Issue 2, 2010, Pages 120-130

  Capewell, Simon ^a   Ford, Earl S ^b   Croft, Janet B ^b   Critchley, Julia A ^c   Greenlund, Kurt J ^b   Labarthe, Darwin R ^b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL;

CARDIOVASCULAR DISEASE; DIABETES; HEALTH RISK; MORTALITY RISK; OBESITY; PUBLIC HEALTH; RISK FACTOR; SMOKING;

ARTICLE; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; HIGH RISK POPULATION; ISCHEMIC HEART DISEASE; MORTALITY; OBESITY; PHYSICAL ACTIVITY; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SMOKING CESSATION; STATISTICAL MODEL; UNITED STATES;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BLOOD PRESSURE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHOLESTEROL; DIABETES COMPLICATIONS; EXERCISE; FEMALE; HEALTH BEHAVIOR; HEALTHY PEOPLE PROGRAMS; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SEX DISTRIBUTION; SMOKING CESSATION; UNITED STATES;

UNITED STATES;

EID: 75649084186     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.08.057885     Document Type: Article

References (51)

1. Heart disease and stroke statistics: 2008 update. Dallas, TX: American Heart Association; 2008.
2. Ford ES, Capewell S. Coronary heart disease mortality among young adults in the US from 1980 through 2002: concealed levelling of mortality rates. J Am Coll Cardiol 2007;50:2128-32. PMID:18036449 doi:10.1016/j. jacc.2007.05.056
3. Department of Health and Human Services. Healthy people 2010: understanding and improving health and objectives for improving health. Washington, DC: Government Printing Office; 2000. Available from: http:// www.cdc.gov/nchs/hphome.htm [accessed on 5 October 2009].
4. Public health action plan to prevent heart disease and stroke. Atlanta, GA: Centers for Disease Control and Prevention; 2008. Available from: http://www. cdc.gov/dhdsp/library/action-plan/index.htm [accessed on 5 October 2009].
5. Centers for Disease Control and Prevention. Prevalence of no leisure-time physical activity - 35 states and the District of Columbia, 1988-2002. MMWR Morb Mortal Wkly Rep. 2004;53:82-6. PMID:14762333
6. Law MR, Wald NJ, Thompson SG. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ 1994;308:367-72. PMID:8043072
7. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360:1903-13. PMID:12493255 doi:10.1016/S0140-6736(02)11911-8
8. Bogers RP, Bemelmans WJ, Hoogenveen RT, Boshuizen HC, Woodward M, Knekt P, et al. Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: a meta-analysis of 21 cohort studies including more than 300 000 persons. Arch Intern Med 2007;167:1720-8. PMID:17846390 doi:10.1001/ archinte.167.16.1720
9. Hunink MG, Goldman L, Tosteson AN, Mittleman MA, Goldman PA, Williams LW, et al. The recent decline in mortality from coronary heart disease, 1980-1990. The effect of secular trends in risk factors and treatment. JAMA 1997;277:535-42. PMID:9032159 doi:10.1001/jama.277.7.535
10. Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE, et al. Explaining the decrease in mortality from coronary heart disease in the United States between 1980 and 2000. N Engl J Med 2007;356:2388-98. PMID:17554120 doi:10.1056/NEJMsa053935
11. Weinstein MC, O'Brien B, Hornberger J, Jackson J, Johannesson M, McCabe C, et al. Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices - Modeling Studies. Value Health 2003;6:9-17. PMID:12535234 doi:10.1046/j.1524-4733.2003.00234.x
12. Goldman L, Phillips KA, Coxson P, Goldman PA, Williams L, Hunink MG, et al. The effect of risk factor reductions between 1981 and 1990 on coronary heart disease incidence, prevalence, mortality and cost. J Am Coll Cardiol 2001;38:1012-7. PMID:11583874 doi:10.1016/S0735-1097(01)01512-1
13. Rose G. The strategy of preventive medicine. Oxford: Oxford University Press; 1992.
14. Emberson J, Whincup P, Morris R, Walker M, Ebrahim S. Evaluating the impact of population and high-risk strategies for the primary prevention of cardiovascular disease. Eur Heart J 2004;25:484-91. PMID:15039128 doi:10.1016/j.ehj.2003.11.012
15. McPherson K, Britton A, Causer L. Coronary heart disease: estimating the impact of changes in risk factors. London: National Heart Forum; 2002. pp. 1-60
16. Capewell S, Beaglehole R, Seddon M, McMurray J. Explanation for the decline in coronary heart disease mortality in Auckland, New Zealand, between 1982 and 1993. Circulation 2000;102:1511-6. PMID:11004141
17. Unal B, Critchley JA, Capewell S. Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation 2004;109:1101-7. PMID:14993137 doi:10.1161/01. CIR.0000118498.35499.B2
18. Laatikainen T, Critchley J, Vartiainen E, Salomaa V, Ketonen M, Capewell S. Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997. Am J Epidemiol 2005;162:764-73. PMID:16150890 doi:10.1093/aje/kwi274
19. Critchley J, Liu J, Zhao D, Wei W, Capewell S. Explaining the increase in coronary heart disease mortality in Beijing between 1984 and 1999. Circulation 2004;110:1236-44. PMID:15337690 doi:10.1161/01. CIR.0000140668.91896.AE
20. Bots ML, Grobbee DE. Decline of coronary heart disease mortality in the Netherlands from 1978 to 1985: contribution of medical care and changes over time in presence of major cardiovascular risk factors. J Cardiovasc Risk 1996;3:271-6. PMID:8863098 doi:10.1097/00043798-199606000-00002
21. Vartiainen E, Puska P, Pekkanen J, Tuomilehto J, Jousilahti P. Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland. BMJ 1994;309:23-7. PMID:8044063
22. Critchley JA, Capewell S. Substantial potential for reductions in coronary heart disease mortality in the UK through changes in risk factor levels. J Epidemiol Community Health 2003;57:243-7. PMID:12646537 doi:10.1136/ jech.57.4.243
23. Unal B, Critchley JA, Capewell S. Small changes in UK cardiovascular risk factors could halve coronary heart disease mortality. J Clin Epidemiol 2005;58:733-40. PMID:15939226 doi:10.1016/j.jclinepi.2004.09.015
24. Stamler J, Stamler R, Neaton JD, Wentworth D, Daviglus ML, Garside D, et al. Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women. JAMA 1999;282:2012-8. PMID:10591383 doi:10.1001/jama.282.21.2012
25. Daviglus ML, Stamler J, Pirzada A, Yan LL, Garside DB, Liu K, et al. Favorable cardiovascular risk profile in young women and long-term risk of cardiovascular and all-cause mortality. JAMA 2004;292:1588-92. PMID:15467061 doi:10.1001/jama.292.13.1588
26. Unal B, Critchley J, Capewell S. IMPACT, a validated comprehensive coronary heart disease model: overview and technical appendices. Liverpool: Liverpool University; 2007. Available from: http://www.liv.ac.uk/PublicHealth/ sc/bua/ impact.html [accessed on 5 October 2009].
27. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364:937-52. PMID:15364185 doi:10.1016/S0140-6736(04)17018-9
28. Briggs A, Sculpher M, Buxton M. Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis. Health Econ 1994;3:95-104. PMID:8044216 doi:10.1002/hec.4730030206
29. Naidoo B, Thorogood M, McPherson K, Gunning-Schepers LJ. Modelling the effects of increased physical activity on coronary heart disease in England and Wales. J Epidemiol Community Health 1997;51:144-50. PMID:9196643 doi:10.1136/jech.51.2.144
30. Capewell S. Predicting future coronary heart disease deaths in Finland and elsewhere. Int J Epidemiol 2006;35:1253-4. PMID:16847019 doi:10.1093/ ije/dyl158
31. Capewell S, Unal B, Critchley JA, McMurray JJ. Over 20 000 avoidable coronary deaths in England and Wales in 2000: the failure to give effective treatments to many eligible patients. Heart 2006;92:521-3. PMID:16537767 doi:10.1136/hrt.2004.053645
32. Daviglus ML, Liu K. Today's agenda: we must focus on achieving favorable levels of all risk factors simultaneously. Arch Intern Med 2004;164:2086-7. PMID:15505120 doi:10.1001/archinte.164.19.2086
33. Hozawa A, Folsom AR, Sharrett R, Chambless LE. Absolute and attributable risks of cardiovascular disease incidence in relation to optimal and borderline risk factors: comparison of African American with white subjects - Atherosclerosis Risk in Communities Study. Arch Intern Med 2007;167:573-9. PMID:17389288 doi:10.1001/archinte.167.6.573
34. Manuel DG, Kwong K, Tanuseputro P, Lim J, Mustard CA, Anderson GM, et al. Effectiveness and efficiency of different guidelines on statin treatment for preventing deaths from coronary heart disease: modelling study. BMJ 2006;332:1419-24. PMID:16737980 doi:10.1136/bmj.38849.487546.DE
35. Capewell S. Will screening individuals at high risk of cardiovascular events deliver large benefits? No. BMJ 2008;337:a1395 PMID:18755771 doi:10.1136/bmj.a1395
36. Dowse GK, Gareeboo H, Alberti KG, Zimmet P, Tuomilehto J, Purran A, et al. Changes in population cholesterol concentrations and other cardiovascular risk factor levels after five years of the non-communicable disease intervention programme in Mauritius. Mauritius Non-communicable Disease Study Group. BMJ 1995;311:1255-9. PMID:7496233
37. Carroll MD, Lacher DA, Sorlie PD, Cleeman JI, Gordon DJ, Wolz M, et al. Trends in serum lipids and lipoproteins of adults, 1960. JAMA 2005;294:1773-81. PMID:16219880 doi:10.1001/jama.294.14.1773
38. Lichtenstein AH, Appel LJ, Brands M, Carnethon M, Daniels S. American Heart Association Nutrition Committee, et al. Diet and lifestyle recommendations revision 2006: a scientific statement from the AHA Nutrition Committee. Circulation 2006;114:82-96. PMID:16785338 doi:10.1161/ CIRCULATIONAHA.106.176158
39. Framework Convention for Tobacco Control [internet site]. Geneva: World Health Organization; 2004. Available from: http://www.who.int/fctc/en/ [accessed on 5 October 2009].
40. Fichtenberg CM, Glantz SA. Association of the California Tobacco Control Program with declines in cigarette consumption and mortality from heart disease. N Engl J Med 2000;343:1772-7. PMID:11114317 doi:10.1056/ NEJM200012143432406
41. Pell JP, Haw S, Cobbe S, Newby DE, Pell AC, Fischbacher C, et al. Smoke-free legislation and hospitalizations for acute coronary syndrome. N Engl J Med 2008;359:482-91. PMID:18669427 doi:10.1056/NEJMsa0706740
42. Tunstall-Pedoe H, Connaghan J, Woodward M, Tolonen H, Kuulasmaa K. Pattern of declining blood pressure across replicate population surveys of the WHO MONICA project, mid-1980s to mid-1990s, and the role of medication. BMJ 2006;332:629-35. PMID:16531419 doi:10.1136/ bmj.38753.779005.BE
43. He FJ, MacGregor GA. How far should salt intake be reduced? Hypertension 2003;42:1093-9. PMID:14610100 doi:10.1161/01. HYP.0000102864.05174.E8
44. Havas S, Roccella EJ, Lenfant C. Reducing the public health burden from elevated blood pressure levels in the United States by lowering intake of dietary sodium. Am J Public Health 2004;94:19-22. PMID:14713688 doi:10.2105/AJPH.94.1.19
45. Dietary guidelines for Americans. Washington, DC: United States Department of Health and Human Services,/Department of Agriculture; 2005.
46. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403. PMID:11832527 doi:10.1056/NEJMoa012512
47. Jain A. Treating obesity in individuals and populations. BMJ 2005; 331:1387-90. PMID:16339251 doi:10.1136/bmj.331.7529.1387
48. Craig CL, Russell SJ, Cameron C, Bauman A. Twenty-year trends in physical activity among Canadian adults. Can J Public Health 2004;95:59-63. PMID:14768744
49. Tudor-Smith C, Nutbeam D, Moore L, Catford J. Effects of the Heartbeat Wales programme over five years on behavioural risks for cardiovascular disease: quasi-experimental comparison of results from Wales and a matched reference area. BMJ 1998;316:818-22. PMID:9549451
50. Unal B, Critchley J, Fidan D, Capewell S. Life-years gained from modern cardiological treatments and population risk factor changes in England and Wales, 1981-2000. Am J Public Health 2005;95:103-8. PMID:15623868 doi:10.2105/AJPH.2003.029579
51. Brotman DJ, Walker E, Lauer MS, O'Brian RG. In search of fewer independent risk factors. Arch Intern Med 2005;165:138-45. doi:10.1001/ archinte.165.2.138